Business Context and Reporting Period
Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) filed this Form 8-K on January 6, 2011, to report the completion of a strategic asset acquisition.
Key Financial Metrics
- Transaction Value: $76.0 million in cash.
- Funding Source: Cash on hand.
- Adjustments: Purchase price is subject to a post-closing inventory adjustment based on a targeted inventory value of $700,000.
- Financial Statements: The filing does not provide specific revenue, profit, or cash flow metrics for the acquired assets or the company as a whole, as pro forma financial information was not required under Regulation S-X Rule 1-02(w).
Material Changes
On January 6, 2011, the Company completed the acquisition of the Dramamine business in the United States from McNEIL-PPC, Inc. The acquired assets include the Dramamine trademark and inventory. This transaction expands the Company's portfolio of over-the-counter healthcare products.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or specific risk factors related to this transaction beyond the standard inventory adjustment contingency. No unusual items were reported.
Investor Verification Checklist
- Verify the final purchase price after the post-closing inventory adjustment against the $700,000 target.
- Confirm the impact of the $76.0 million cash outflow on the Company's liquidity position in subsequent filings.
- Review future quarterly reports for the integration progress and revenue contribution of the Dramamine brand.